Sobre
Dr Alzouebi is a Consultant Clinical Oncologist at Weston Park Hospital, specialising in the treatment of cancers of the urinary tract, particularly prostate, kidney, and bladder cancer. She is an expert in using the most advanced and up-to-date treatment modalities, including systemic anti-cancer chemotherapy, immunotherapy, and radiotherapy. Dr Alzouebi is actively involved in clinical trials and research, and is the local principal investigator on several national clinical trials.
She completed her general medical training in the Yorkshire Deanery, achieving MRCP and DTMH qualifications, and completed the Clinical Oncology Training Programme at Weston Park Hospital in Sheffield. She obtained a Distinction in a Master’s Degree in Oncology from the University of Nottingham and her dissertation research was published in a peer-reviewed journal. Dr Alzouebi holds a substantive NHS post as a Consultant Clinical Oncologist at Sheffield Teaching Hospital NHS Foundation Trust.
Her treatments include Systemic Drug Therapy/Chemotherapy (Novel Targeted Anticancer Drug Treatment, Systemic Chemotherapy, Immunotherapy, Monoclonal Antibodies, Endocrine Therapy, Radium-223, and Tyrosine Kinase therapy) and Radiotherapy (Intensity Modulated Radiotherapy, Image Guided Radiotherapy, Adaptive Radiotherapy, Stereotactic Ablative Radiotherapy, and SABR). Her areas of interest include Advanced Radiotherapy Techniques for Prostate and Bladder Cancer, Prostate SABR, and Chemotherapy in Prostate, Kidney, and Bladder Cancer. Dr Alzouebi also works in partnership with Genesiscare to offer SpaceOAR for prostate radiotherapy.
She completed her general medical training in the Yorkshire Deanery, achieving MRCP and DTMH qualifications, and completed the Clinical Oncology Training Programme at Weston Park Hospital in Sheffield. She obtained a Distinction in a Master’s Degree in Oncology from the University of Nottingham and her dissertation research was published in a peer-reviewed journal. Dr Alzouebi holds a substantive NHS post as a Consultant Clinical Oncologist at Sheffield Teaching Hospital NHS Foundation Trust.
Her treatments include Systemic Drug Therapy/Chemotherapy (Novel Targeted Anticancer Drug Treatment, Systemic Chemotherapy, Immunotherapy, Monoclonal Antibodies, Endocrine Therapy, Radium-223, and Tyrosine Kinase therapy) and Radiotherapy (Intensity Modulated Radiotherapy, Image Guided Radiotherapy, Adaptive Radiotherapy, Stereotactic Ablative Radiotherapy, and SABR). Her areas of interest include Advanced Radiotherapy Techniques for Prostate and Bladder Cancer, Prostate SABR, and Chemotherapy in Prostate, Kidney, and Bladder Cancer. Dr Alzouebi also works in partnership with Genesiscare to offer SpaceOAR for prostate radiotherapy.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Mymoona Alzouebi
Educação e formação
-
2005–2011 MD · Medicine and Surgery
-
2011–2015 Residency · Oncologia
Carreira e nomeações
-
2015-09–2016-08 Junior consultant
Licenças e seguros
Licenças médicas
GB — Organización Médica Colegial de España (OMC)
Certificações do conselho
European Board of Oncologia
Seguro de responsabilidade profissional:
AXA Healthcare Liability · 1,000,000 EUR cobertura · No claims on file
Procedimentos realizados
| Procedimento | Código | Total acumulado |
|---|---|---|
| GP consultation | 99213 | 1,819 |
| Annual physical exam | 99395 | 1,237 |
| Vaccination administration | 90471 | 1,053 |
| Minor procedure (skin) | 17110 | 586 |
Serviços e preços
| Serviço | Duração | Modalidade | Preço |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 90 min | in_clinic | 360.00 EUR |
| Minor procedure (skin) | 60 min | in_clinic | 270.00 EUR |
Consultório, equipa e na prática
Vídeos
Investigação e publicações
índice h: 15 · i10: 15
-
Long-term follow-up of Oncologia across GB
DOI: 10.9711/euroclin.2026.0 · PMID: 36234510 · citado por 187
-
Validation of clinical scoring in Oncologia
DOI: 10.9456/euroclin.2025.1 · PMID: 31706029 · citado por 81
-
Long-term follow-up of Oncologia across GB
DOI: 10.9648/euroclin.2024.2 · PMID: 36028681 · citado por 39
-
Validation of clinical scoring in Oncologia
DOI: 10.3301/euroclin.2023.3 · PMID: 37363220 · citado por 37
Palestras convidadas
- Practical updates in Oncologia European Annual Congress (Oncologia) · Vienna · 2024 · invited
- Single-centre experience in Oncologia National Society Meeting · Sheffield · 2023 · oral abstract
Prémios e afiliações
Prémios
- 🏆 Top-rated Oncologia — Sheffield · EuroClinics Patient Choice · 2025 · regional
Filiações em sociedades
- WONCA Europe — Family Doctors — Member · Desde 2016
- national college of family doctors — Member · Desde 2016
- European Union of Medical Specialists (UEMS) — Member · Desde 2016
Artigos deste médico
- Patient education Patient guide to Oncologia
- Awareness When should you see a oncologia?
Para pacientes internacionais
- Coordenador
- Patient liaison · dr.mymoona.alzouebi@euroclinics.example
Localização
1 etiquetaAvaliações dos pacientes
Partilhe a sua experiência — ajude outros pacientes a encontrar o médico certo. Escrever uma avaliação →
Avaliações recentes
-
★★★★★ ✓ Verificado Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verificado Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verificado Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.